Scientific Integrity Policy Updates From FDA, CDC And NIH Due At White House In July
Executive Summary
HHS-wide update will address agency integrity improvements in the wake of concerns that political considerations inappropriately influenced regulatory decisions related to COVID-19 during the Trump Administration, the General Accountability Office notes in a new report.